An enzyme hydrolyzing methylated inhibitors of nitric oxide synthase is present in circulating human red blood cells

References

• Valiance P., Leone A., Calver A., Collier J., Moncada S. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 1992; 339: 572–575
   PubMedGoogle Scholar
• Surdacki A., Nowicki M., Sandmann J., Tsikas D., Boeger R., Bode-Boeger S., Kruszelnicka-Kwiatkowska O., Kokot F., Dubiel J., Froelich J. Reduced urinary excretion of nitric oxide metabolites and increased plasma levels of asymmetric dimethylarginine in men with essential hypertension. Journal of Cardiovascular Pharmacology 1999; 33: 652–658
   PubMed Web of Science ®Google Scholar
• Usui M., Matsuoka H., Miyazaki H., Ueda S., Okuda S., Imaizumi T. Increased endogenous nitric oxide synthase inhibitor in patients with congestive heart failure. Life Sciences 1998; 62: 2425–2430
   PubMed Web of Science ®Google Scholar
• Miyazaki H., Matsuoka H., Cooke J., Usui M., Ueda S., Okuda S., Imaizumi T. Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis. Circulation 1999; 99: 1141–1146
   PubMed Web of Science ®Google Scholar
• Boger R., Bode-Boger S., Thiele W., Junker W., Alexander K., Frolich J. Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease. Circulation 1997; 95: 2068–2074
   PubMed Web of Science ®Google Scholar
• Boger R., Bode-Boger S., Szuba A., Tsao P., Chan J., Tangphao O., Blaschke T., Cooke J. Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia. Circulation 1998; 98: 1842–1847
   PubMed Web of Science ®Google Scholar
• Rawal N., Lee Y., Whitaker J., Park J., Paik W., Kim S. Urinary excretion of NG dimethylarginines in multiple sclerosis patients: preliminary observations. Journal of Neurological Science 1995; 129: 186–191
   PubMedGoogle Scholar
• Das I., Khan N., Puri B., Hirsch S. Elevated endogenous nitric oxide synthase inhibitor in schizophrenic plasma may reflect abnormalities in brain nitric oxide production. Neuroscience Letters 1996; 215: 209–211
   PubMed Web of Science ®Google Scholar
• Moncada S. The l-arginine-nitric oxide pathway. New England Journal of Medicine 1993; 329: 2002–2010
   PubMed Web of Science ®Google Scholar
• Morris S.M., Jr, Billiar T.R., Jr. New insights into the regulation of inducible nitric oxide synthesis. American Journal of Physiology 1994; 266: E829–E839
   PubMed Web of Science ®Google Scholar
• Kakimoto Y., Akazawa S. Isolation and identification of NG,NG- and NG,N′G-dimethylarginine, NG-mono, di-, and trimethyllysine, and glucosylgalactosyl-and galactosyl-d-hydroxylysine from human urine. Journal of Biological Chemistry 1970; 245: 5751–5758
   PubMed Web of Science ®Google Scholar
• Paik W., Kim S. Protein methylation. Science 1971; 1974: 114–119
   Web of Science ®Google Scholar
• Paik W., Kim S. Protein methylation: Chemical, enzymological, and biological significance. Advances in Enzymology, A. Meister. Wiley, New York 1975; 42: 227–286, In
   Google Scholar
• Ogawa T., Kimoto M., Watanabe H., Sasaoka K. Metabolism of NG,NG- and NG,N′G-dimethylardimethylarginine in rats. Archives of Biochemistry and Biophysics 1987; 252: 526–537
   PubMed Web of Science ®Google Scholar
• Ogawa T., Kimoto M., Sasaoka K. Dimethylarginine: pyruvate aminotransferase in rats. Purification, properties, and identity with alanine: glyoxylate aminotransferase 2. Journal of Biological Chemistry 1990; 265: 20938–20945
   PubMedGoogle Scholar
• Ogawa T., Kimoto M., Sasaoka K. Occurrence of a new enzyme catalyzing the direct conversion of NG,NG-dimethyl-l-arginine to l-citrulline in rats. Biochemical and Biophysical Research Communications 1987; 148: 671–677
   PubMed Web of Science ®Google Scholar
• Brusilow S., Horwich A. Urea cycle enzymes. The Metabolic and Molecular Bases of Inherited Disease, C.R. Striver, A.L. Beaudet, W.S. Sly, D. Valle. McGraw-Hill, New York 1995; 1: 1187–1232, In
   Google Scholar
• Hecker M., Sessa W., Harris H., Anggard E., Vane J. The metabolism of l-arginine and its significance for the biosynthesis of endothelium-derived relaxing factor: cultured endothelial cells recycle l-citrulline to l-arginine. Proceedings of the National Academy of Science USA 1990; 87: 8612–8616
   PubMed Web of Science ®Google Scholar
• Hecker M., Mitchell J., Harris H., Katsura M., Thiemermann C., Vane J. Endothelial cells metabolize NG-monomethyl-l-arginine to l-citrulline and subsequently to l-arginine. Biochemical and Biophysical Research Communications 1990; 167: 1037–1043
   PubMed Web of Science ®Google Scholar
• Yu Y., Terada K., Nagasaki A., Takiguchi M., Mori M. Preparation of recombinant argininosuccinate synthetase and argininosuccinate lyase: expression of the enzymes in rat tissues. Journal of Biochemistry 1995; 117: 952–957
   PubMedGoogle Scholar
• Arnt-Ramos L., O'Brien W., Vincent S. Immunohistochemical localization of argininosuccinate synthetase in the rat brain in relation to nitric oxide synthase-containing neurons. Neuroscience 1992; 51: 773–789
   PubMedGoogle Scholar
• Isayama H., Nakamura H., Kanemaru H., Kobayashi K., Emson P., Kawabuchi M., Tashiro N. Distribution and co-localization of nitric oxide synthase and argininosuccinate synthetase in the cat hypothalamus. Archives of Histology and Cytology 1997; 60: 477–492
   PubMedGoogle Scholar
• Mori M., Gotoh T., Nagasaki A., Takiguchi M., Sonoki T. Regulation of the urea cycle enzyme genes in nitric oxide synthesis. Journal of Inherited Metabolic Diseases 1998; 21: 59–71
   PubMedGoogle Scholar
• Kimoto M., Tsuji H., Ogawa T., Sasaoka K. Detection of NG,NG-dimethylarginine dimethylaminohydrolase in the nitric oxide-generating systems of rats using monoclonal antibody. Archives of Biochemistry and Biophysics 1993; 300: 657–662
   PubMed Web of Science ®Google Scholar
• Kimoto M., Whitley G., Tsuji H., Ogawa T. Detection of NG,NG-dimethylarginine dimethylaminohydrolase in human tissues using a monoclonal antibody. Journal of Biochemistry (Tokyo) 1995; 117: 237–238
   PubMed Web of Science ®Google Scholar
• Kimoto M., Miyatake S., Sasagawa T., Yamashita H., Okita M., Oka T., Ogawa T., Tsuji H. Purification, cDNA cloning and expression of human NG,NG-dimethylarginine dimethylaminohydrolase. European Journal of Biochemistry 1998; 258: 863–868
   PubMedGoogle Scholar
• Boyum A. Isolation of mononuclear cells and granulocytes from human blood. Scandinavian Journal of Clinical Laboratory Investigation 1968; 21: 77–89
   PubMed Web of Science ®Google Scholar
• Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 1951; 193: 265–268
   PubMed Web of Science ®Google Scholar
• Ogawa T., Kimoto M., Sasaoka K. Purification and properties of a new enzyme, NG,NG-dimethylarginine dimethylaminohydrolase, from rat kidney. Journal of Biological Chemistry 1989; 264: 10205–10209
   PubMed Web of Science ®Google Scholar
• Prescott L., Jones M. Modified methods for the determination of carbamyl aspartate. Analytical Biochemistry 1969; 32: 408–419
   PubMed Web of Science ®Google Scholar
• Beal D., Bryan G. Quantitative spectrophotometric determination of human and rat urinary dimethylamine. Biochemical Medicine 1978; 19: 374–382
   PubMedGoogle Scholar
• Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680–685
   PubMed Web of Science ®Google Scholar
• MacAllister R., Parry H., Kimoto M., Ogawa T., Russell R., Hodson H., Whitley G., Valiance P. Regulation of nitric oxide synthesis by dimethylarginine dimethylaminohydrolase. British Journal of Pharmacology 1996; 119: 1533–1540
   PubMed Web of Science ®Google Scholar
• Bogumil R., Knipp M., Fundel S., Vasak M. Characterization of dimethylargininase from bovine brain: evidence for a zinc binding site. Biochemistry 1998; 37: 4791–4798
   PubMed Web of Science ®Google Scholar
• Ischiropoulos H., Zhu L., Chen J., Tsai M., Martin J., Smith C., Beckman J. Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase. Archives of Biochemistry and Biophysics 1992; 298: 431–437
   PubMed Web of Science ®Google Scholar
• Kang E.S., Tevlin M.T., Wang Y.B., Chiang T.M., Cardenas R., Myers L.K., Acchiardo S.R. Hemodialysis hypotension: interaction of inhibitors, iNOS, and the interdialytic period. American Journal of the Medical Sciences 1999; 317: 1–14
   PubMed Web of Science ®Google Scholar
• Fickling S., Leone A., Nussey S., Valiance P., Whitley G. Synthesis of NG, NG dimethylarginine by human endothelial cells. Endothelium 1993; 1: 137–140
   Google Scholar
• Mendes Ribeiro A., Roberts N., Lane C., Yacoob M., Ellory J. Accumulation of the nitric oxide antagonist N-monomethyl-l-arginine in end stage renal failure patients on regular haemodialysis. Experimental Physiology 1996; 81: 475–481
   PubMedGoogle Scholar
• Fervenza F., Hendry B., Ellory J. Effects of dialysis and transplantation on red cell sodium pump function in renal failure. Nephron 1989; 53: 121–128
   PubMed Web of Science ®Google Scholar
• Kielstein J., Boger R., Bode-Boger S., Schaffer J., Barbey M., Koch K., Frolich J. Asymmetric dimethylarginine plasma concentrations differ in patients with end-stage renal disease: relationship to treatment method and atherosclerotic disease. Journal of the American Society of Nephrology 1999; 10: 594–600
   PubMed Web of Science ®Google Scholar
• Ito A., Tsao P., Adimoolam S., Kimoto M., Ogawa T., Cooke J. Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase. Circulation 1999; 99: 3092–3095
   PubMed Web of Science ®Google Scholar
• Masuda H., Goto M., Tamaoki S., Azuma H. Accelerated intimal hyperplasia and increased endogenous inhibitors for NO synthesis in rabbits with alloxan-induced hyperglycaemia. British Journal of Pharmacology 1999; 126: 211–218
   PubMedGoogle Scholar